Bruce Springsteen fans can rejoice as the rocker has announced a new studio album with the E Street Band.
— FOX News: Melissa Roberto
Author: Michelle Dryden
Wildfires in California, Oregon and Washington State have killed seven people, with growing fears more have died in towns destroyed throughout the West.
— NYT: Melissa Roberto
Jane Fraser, Citigroup’s president, will replace Chief Executive Michael Corbat in February as he retires.
— NYT: Michael J. de la Merced and Emily Flitter
OLDWICK, N.J.–(BUSINESS WIRE)–AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” of Trinidad & Tobago Insurance Limited (TATIL) (Trinidad and Tobago). The outlook of these Credit Ratings (ratings) is stable.
The ratings reflect TATIL’s balance sheet strength, which AM Best categorizes as strongest, as well as its strong operating performance, limited business profile and appropriate enterprise risk management.
TATIL’s balance sheet strength is supported by its risk-adjusted capitalization being at the strongest level, as measured by Best’s Capital Adequacy Ratio (BCAR). A profitable overall earnings trend as well as an effective reinsurance program that mitigates catastrophic loss, have enhanced TATIL’s surplus growth and level of risk-adjusted capitalization.
TATIL has produced favorable underwriting results consistently and this has been augmented by a stable level of investment and rental income resulting in historically profitable overall operating performance. These factors are somewhat offset by the geographic concentration of TATIL’s operations, the continuing challenge to maintain earnings and market share in extremely competitive markets, as well as the inherent exposure to the potential impact from catastrophe events.
This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best’s Credit Ratings. For information on the proper media use of Best’s Credit Ratings and AM Best press releases, please view Guide for Media – Proper Use of Best’s Credit Ratings and AM Best Rating Action Press Releases.
AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in New York, London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.
Copyright © 2020 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.
Contacts
Ricardo Longchallon
Senior Financial Analyst
+1 908 439 2200, ext. 5676
ricardo.longchallon@ambest.com
Sharon Marks
Associate Director
+1 908 439 2200, ext. 5477
sharon.marks@ambest.com
Christopher Sharkey
Manager, Public Relations
+1 908 439 2200, ext. 5159
christopher.sharkey@ambest.com
Jim Peavy
Director, Public Relations
+1 908 439 2200, ext. 5644
james.peavy@ambest.com
OLDWICK, N.J.–(BUSINESS WIRE)–AM Best has assigned an indicative Long-Term Issue Credit Rating of “a-” to the forthcoming new senior unsecured notes to be issued by OneAmerica Financial Partners, Inc. (OneAmerica). The outlook assigned to this Credit Rating (rating) is stable, which is in line with the outlook of OneAmerica’s Long-Term Issuer Credit Rating.
OneAmerica intends to use the proceeds of this issue for general corporate purposes. AM Best expects OneAmerica’s financial leverage ratio to increase slightly but remain within target levels. AM Best will continue to monitor OneAmerica’s interest coverage and leverage ratios.
This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best’s Credit Ratings. For information on the proper media use of Best’s Credit Ratings and AM Best press releases, please view Guide for Media – Proper Use of Best’s Credit Ratings and AM Best Rating Action Press Releases.
AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in New York, London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.
Copyright © 2020 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.
Contacts
Anthony McSwieney
Senior Financial Analyst
+1 908 439 2200, ext. 5715
anthony.mcswieney@ambest.com
Edward Kohlberg
Director
+1 908 439 2200, ext. 5664
edward.kohlberg@ambest.com
Christopher Sharkey
Manager, Public Relations
+1 908 439 2200, ext. 5159
christopher.sharkey@ambest.com
Jim Peavy
Director, Public Relations
+1 908 439 2200, ext. 5644
james.peavy@ambest.com
CRANBURY, N.J.–(BUSINESS WIRE)–Innophos Inc., a leading producer of specialty phosphates, announces that the US Patent and Trademark Office Patent, has issued US Patent 10,767,118 on September 8, 2020. The patent covers a family of metal-based scavengers that reduce hydrogen sulfide emissions in asphalt, thereby improving the safety of those working with the asphalt and reducing equipment corrosion. The patent has an expiration date of August 2, 2036.
Hydrogen Sulfide (H2S) in Asphalt
H2S is a naturally occurring gas that is found in crude oil and its derivatives from the refining process, such as asphalt. H2S is also formed by the degradation of sulfur compounds in the oil when it is exposed to high temperatures or catalysts in the refining process. H2S is a toxic and corrosive gas, and its presence can lead to hazardous conditions for humans and equipment. To reduce H2S in asphalt, many asphalt producers and terminals use metal-based scavengers to remove the H2S prior to transporting to downstream destinations.
About INNOVALT® Scavenger
When liquid asphalt is modified with polyphosphoric acid (PPA) to achieve a higher performance grade for use in asphalt pavements, not all metal-based H2S scavengers are capable of withstanding the transiently acidic environment created by the PPA resulting in the increased release of H2S. INNOVALT® SL70’s newly patented, metal-based liquid technology is capable of withstanding the acidic condition generated in asphalt when it is PPA-modified and maintains the metal sulfide bond in suspension instead of releasing H2S into the storage vessel’s headspace.
“This patent expands Innophos’ portfolio in the PPA-modified asphalt space in which Innophos has been a lead innovator over the past 25 years with several patent-protected applications,” said Sherry Duff, Chief Marketing and Technology Officer. “It’s very exciting to see how our solution allows the asphalt industry to achieve a higher level of performance for their products while improving the safety of those working with the asphalt.”
About the Company
Innophos is a leading international producer of essential ingredients. We partner with world-leading health & nutrition, food & beverage, and industrial brands to create science-based solutions that improve quality of life. Our knowledgeable teams apply science to unlock the potential that lies within the blends and formulations that we deliver. Forward thinking and people centric at heart, we execute with purpose and efficiency to create value in everything we do. Headquartered in Cranbury, New Jersey, Innophos has manufacturing operations across the United States, in Canada, Mexico and China. For more information, please visit www.innophos.com.
Contacts
Eugenia Erlij, VP of Marketing and Communications
eugenia.erlij@innophos.com
614.787.6756
Susan M. O’Brien, M.D., one of the nation’s foremost leukemia experts, discusses the future of frontline therapies and upcoming clinical trials associated with chronic lymphocytic leukemia.
CRANBURY, N.J.–(BUSINESS WIRE)–#BloodCancerAwarenessMonth–In support of Blood Cancer Awareness Month and World Lymphoma Awareness Day, the CURE® Speaking Out announces a four-episode video series titled, “Understanding Chronic Lymphocytic Leukemia,” featuring Susan M. O’Brien, M.D., professor and associate director for clinical science, Chao Family Comprehensive Cancer Center at the University of California, Irvine. O’Brien is a spokesperson for The Leukemia & Lymphoma Society (LLS).
“We are proud to work with experts such as Dr. Susan O’Brien on behalf of LLS to increase awareness and support for those with blood cancers,” said Mike Hennessy Jr., president and CEO of MJH Life Sciences™, parent company of CURE Media Group. “Through our Speaking Out video series, we are committed to increasing public understanding of these diseases and providing our viewers and readers access to breaking treatment news and resources they can share with patients, caregivers and survivors.”
During this series, O’Brien discusses a variety of topics related to chronic lymphocytic leukemia. In the first episode, she provides an overview of the basics of the disease, including signs, symptoms and risk factors. In the following episodes, O’Brien reviews the future of frontline therapies in chronic lymphocytic leukemia, as well as recommendations on how to live with the disease long term and how to join a clinical trial.
“Currently we have so many great options for frontline therapy of CLL that we can find an option that is right for any patient,” said Dr. O’Brien.
CURE® Speaking Out is a video platform designed to offer patients, caregivers and advocates as much information as possible for their cancer journey. In parallel with its print columns, CURE® provides patients and caregivers with firsthand information from experts in the field. Throughout each video series, CURE® works with leading cancer advocacy groups to offer advice and assistance to individuals across various cancer types, as well as their caregivers, advocates and health care professionals, to provide cancer updates, research, and education.
To view the complete video series, click here.
About CURE Media Group
CURE Media Group is the leading resource for cancer updates, research and education. It features a full suite of media products, including the industry-leading website, CUREtoday.com; innovative video programs, such as “CURE Connections®,” a series of widely attended live events; CURE® magazine, which reaches more than 1 million readers; and the dynamic website for oncology nurses, OncNursingNews.com, and its companion publication, Oncology Nursing News®. CURE Media Group is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America, dedicated to delivering trusted health care news across multiple channels.
About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society® (LLS) is a global leader in the fight against cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.
Founded in 1949 and headquartered in Rye Brook, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org. Patients should contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 9 p.m. ET.
For additional information visit lls.org/lls-newsnetwork. Follow us on Facebook, Twitter, and Instagram
Contacts
CURE Media Group:
Alexandra Ventura
609-716-7777, ext. 121
The military-inspired shirts, hats and gear are being sold to raise money for disabled American veterans (DAV) and Blue Star Families.
— FOX News: Gary Gastelu
Sen. Josh Hawley, R-Mo., is planning to submit a bill to Congress on Wednesday authorizing the Justice Department to raise the salaries of state and local police forces all across the country — except in cities that have chosen to defund law enforcement in the wake of nationwide protests and riots.
— FOX News: Nick Givas
The liberal media want you to believe that former Vice President Joe Biden would challenge Beijing if he is elected as president — but no amount of media spin can transform a serial China appeaser into a bold American leader.
— FOX News: Mike Huckabee